β-Blocker and Colchicine Coingestion in the Setting of Cocaine Intoxication

Olivia Levine, MD, PhD; Souparno Mitra, MD

Prim Care Companion CNS Disord 2025;27(3):25cr03920

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (8)

Suen LW, Davy-Mendez T, LeSaint KT, et al. Emergency department visits and trends related to cocaine, psychostimulants, and opioids in the United States, 2008-2018. BMC Emerg Med. 2022;22(1):19. CrossRef
Ghuran A, Nolan J. The cardiac complications of recreational drug use. West J Med. 2000;173(6):412–415. PubMed CrossRef
Carbone MG, Maremmani I. Chronic cocaine use and Parkinson’s disease: an interpretative model. Int J Environ Res Public Health. 2024;21(8):1105. CrossRef
Richards JR, Hollander JE, Ramoska EA, et al. β Blockers, cocaine, and the unopposed α-stimulation phenomenon. J Cardiovasc Pharmacol Ther. 2017;22(3):239–249. CrossRef
Book WM. Carvedilol: a nonselective beta blocking agent with antioxidant properties. Congest Heart Fail. 2002;8(3):173–190. CrossRef
de Lange DW, Sikma MA, Meulenbelt J. Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol (Phila). 2013;51(5):385–393. PubMed CrossRef
Kumar A, Dogra S. Neuroprotective effect of carvedilol, an adrenergic antagonist against colchicine induced cognitive impairment and oxidative damage in rat. Pharmacol Biochem Behav. 2009;92(1):25–31. PubMed CrossRef
Khalid MM, Galuska MA, Hamilton RJ. Beta-blocker toxicity. [Updated 2023 Jul 28]. In: StatPearls [Internet]. StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK448097/